InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
T+90 hit rate
50%
T+90 mean return
-2.7%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Gloria Melanie, Chief Operating Officer. Director active across 2 companies, notably Immunovant, Inc.. In total, 10 filings have been published. Split: 0 buy · 6 sells. Total volume traded: €437k. Activity tracked since 16 August 2023. The latest transaction was filed on 8 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
14,748 sharesCommon StockSEC:0001764013-26-000075:0
2,966 sharesCommon StockSEC:0001764013-26-000075:1
8,722 shares@ US$24.830.0033% mcap42.5% of flowCommon StockSEC:0001973838-26-000004:0
8,722 shares@ US$24.830.0033% mcap42.5% of flowCommon StockSEC:0001973838-26-000004
1,437 shares@ US$26.980.0006% mcap7.5% of flowCommon StockSEC:0001764013-26-000013:0
1,437 shares@ US$26.987.5% of flowCommon StockSEC:0001764013-26-000013
76,181 shares0Common StockSEC:0001764013-25-000057:0
109,956 shares0Common StockSEC:0001764013-24-000188:0
10,298 shares@ US$4.47100.0% of flowCommon StockSEC:0001962918-24-000063:0
140,584 shares0Common StockSEC:0001962918-23-000022:0
10 of 10 declarations
About Gloria Melanie
Gloria Melanie is the Chief Operating Officer at Immunovant, Inc. She is responsible for managing the daily operations of the company, ensuring efficiency and alignment of activities with strategic objectives. Her role also involves overseeing teams and implementing innovative solutions to enhance the company's performance in the biotechnology sector.
